Acutaas Chemicals Limited — Financials & Forensics
Sector: Healthcare · NSE: ACUTAAS · BSE: 543349 · ISIN: INE00FF01025
11 Sep 2026
Add ACUTAAS to your watchlist — all of this, automated.
Sign in with GoogleAnnual P&L snapshot
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue from operations | ₹520 Cr | ₹617 Cr | ₹717 Cr | ₹1,007 Cr | ₹1,339 Cr |
| EBITDA | ₹105 Cr | ₹123 Cr | ₹128 Cr | ₹232 Cr | ₹480 Cr |
| EBITDA margin | 20.2% | 19.9% | 17.9% | 23.1% | 35.9% |
| Profit after tax | ₹72 Cr | ₹83 Cr | ₹49 Cr | ₹160 Cr | ₹356 Cr |
Deeper analysis
Recent filings by Acutaas Chemicals Limited
-
Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 is attached.
10 Sep 2026 · General Update
-
General Updates
04 Sep 2026 · General Update
-
Newspaper publication for dispatch of notice of 19th AGM along with Annual Report for the FY 2025-26
31 Aug 2026 · Corporate Action
-
Shareholders meeting
29 Aug 2026 · Corporate Action
-
Communication to shareholders issued in respect of deduction of TDS on Dividend , is herewith enclos
29 Aug 2026 · Corporate Action
Never miss a filing again
About Acutaas Chemicals Limited on Indian Stock Alerts
Indian Stock Alerts tracks Acutaas Chemicals Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.
Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.